Thomas Meyer is the founder of Altamira Therapeutics. Altamira Therapeutics has raised $4M in total funding. Latest round: Post-IPO equity.
Thomas Meyer is the Founder, Chairman, and CEO of Altamira Therapeutics Ltd., a pharmaceutical company focused on RNA therapeutics. He recently led a $4 million public offering of common shares in 2024 to support the company's financial position and strategic business model transition. Meyer has presented the company's pipeline and ongoing transformation at investor conferences.
Full founder directory · Investor directory · Company funding database · Fundraising library